Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Review
Leukemia
2026
Measurable residual disease assessment in multiple myeloma.
Saurabh Zanwar et al.
PubMed ↗
Publisher ↗
No numbers read from the abstract.
Not cited yet
Measurable residual disease assessment in multiple myeloma. | OpenQuestion